申请人:ACTELION PHARMACEUTICALS LTD
公开号:US20160107997A1
公开(公告)日:2016-04-21
The present invention relates to derivatives of formula (I)
wherein (R
1
)
n
, R
2a
, R
2b
, R
3a
, R
3b
, R
4
, L
1
, L
2
, X, Y and Ar
1
are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.
本发明涉及公式(I)的衍生物,其中(R1)n,R2a,R2b,R3a,R3b,R4,L1,L2,X,Y和Ar1如描述中所述,其制备方法,其制备的药学上可接受的盐,以及它们作为药物的用途,包括含有一个或多个公式(I)化合物的药物组合物,尤其是它们作为CXCR7受体调节剂的用途。